small molecule

PIZENSY

LACTITOL

Loss of exclusivityMay 2037latest FDA-listed patent expiry
CompanyBraintreeView the full company profile on CliffBio

Drug detail

Brand namePIZENSY
Active ingredientLACTITOL
Strength10GM
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
10806743May 2037use U-1516

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PIZENSY patent cliff — loss of exclusivity May 2037 | CliffBio